BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25714048)

  • 1. Epigenetics in gastric carcinogenesis: TET genes as important players.
    Necula LG; Mambet C; Albulescu R; Diaconu CC
    J Immunoassay Immunochem; 2015; 36(5):445-55. PubMed ID: 25714048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-eleven translocase: key regulator of the methylation landscape in cancer.
    Shekhawat J; Gauba K; Gupta S; Choudhury B; Purohit P; Sharma P; Banerjee M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1869-1879. PubMed ID: 33913031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demethylation of the RB1 promoter concomitant with reactivation of TET2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice.
    Cao D; Jia Z; Wu Y; Su T; Zhao D; Wu M; Tsukamoto T; Oshima M; Jiang J; Cao X
    Life Sci; 2020 Dec; 263():118580. PubMed ID: 33058920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
    Cheng YY; Yu J; Wong YP; Man EP; To KF; Jin VX; Li J; Tao Q; Sung JJ; Chan FK; Leung WK
    Br J Cancer; 2007 Oct; 97(7):895-901. PubMed ID: 17848950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer type-specific epigenetic changes: gastric cancer.
    Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
    Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic alterations in gastric carcinogenesis.
    Choi IS; Wu TT
    Cell Res; 2005 Apr; 15(4):247-54. PubMed ID: 15857579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.
    Asada K; Ando T; Niwa T; Nanjo S; Watanabe N; Okochi-Takada E; Yoshida T; Miyamoto K; Enomoto S; Ichinose M; Tsukamoto T; Ito S; Tatematsu M; Sugiyama T; Ushijima T
    Oncogene; 2013 Apr; 32(17):2140-9. PubMed ID: 22689052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic and epigenetic alterations in gastric carcinogenesis].
    Ushijima T; Yoshida S
    Nihon Rinsho; 2012 Oct; 70(10):1705-14. PubMed ID: 23198549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer.
    Otani K; Li X; Arakawa T; Chan FK; Yu J
    Expert Rev Mol Diagn; 2013 Jun; 13(5):445-55. PubMed ID: 23782252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.
    Nojima M; Suzuki H; Toyota M; Watanabe Y; Maruyama R; Sasaki S; Sasaki Y; Mita H; Nishikawa N; Yamaguchi K; Hirata K; Itoh F; Tokino T; Mori M; Imai K; Shinomura Y
    Oncogene; 2007 Jul; 26(32):4699-713. PubMed ID: 17297461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
    Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
    Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of TET family proteins and 5-hydroxymethylcytosine in human tumors.
    Wu YC; Ling ZQ
    Histol Histopathol; 2014 Aug; 29(8):991-7. PubMed ID: 24585390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portraits of TET-mediated DNA hydroxymethylation in cancer.
    Jeschke J; Collignon E; Fuks F
    Curr Opin Genet Dev; 2016 Feb; 36():16-26. PubMed ID: 26875115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.
    Wen XZ; Akiyama Y; Baylin SB; Yuasa Y
    Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Developing technologies for epigenomic analysis and clinical application of molecular diagnosis].
    Yamamoto E; Suzuki H; Maruyama R; Shinomura Y
    Rinsho Byori; 2012 Jul; 60(7):637-43. PubMed ID: 22973723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.